Correct option is D
The correct answer is (d) Bharat Biotech, India.
· ZikaVac is the first vaccine for the Zika virus developed by Bharat Biotech, an Indian biotechnology company.
· Bharat Biotech announced the development of ZikaVac in response to the global spread of the Zika virus, which has been linked to severe birth defects in newborns. The company utilized its expertise in vaccine development to produce ZikaVac, which went through pre-clinical trials and was aimed at offering protection against the virus.
Information Booster:
· Zika virus is primarily spread by the Aedes mosquito and can also be transmitted through blood and sexual contact.
· Bharat Biotech developed ZikaVac to prevent Zika virus infections, which are linked to neurological disorders and birth defects such as microcephaly.
· This vaccine reflects India’s growing role in vaccine research and development on a global scale.
· Bharat Biotech is also known for developing vaccines for other diseases, including Covaxin for COVID-19.
· Developing a vaccine for the Zika virus was a significant step due to the virus's rapid spread and potential to cause congenital disabilities.